FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option.
Elendu C, Okahia TW, Blewusi GS, Meduoye OOM, Ogelle EC, Egbo AR, Nwankwo VC, Amaefule KC, Emechebe SL, Mohamed AA, Ogedengbe OS, Aggreh OP, Obi DI, Orji VI, Bakare SO, Adediran FD, Adetoye F, Akande BA, Ogunsola OC, Olanlege AM.
Elendu C, et al.
Ann Med Surg (Lond). 2025 Jul 30;87(9):5373-5377. doi: 10.1097/MS9.0000000000003670. eCollection 2025 Sep.
Ann Med Surg (Lond). 2025.
PMID: 40901162
Free PMC article.
Menopausal vasomotor symptoms (VMS), such as hot flashes and night sweats, significantly impact the quality of life for many women. ...Fezolinetant modulates the activity of KNDy neurons in the hypothalamus, which plays a key role in thermoregul …
Menopausal vasomotor symptoms (VMS), such as hot flashes and night sweats, significantly impact the quality of life for …